Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
bioMerieux (BMXMF) had Stock-Based Compensation of $14.30M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.58B |
|
$1.64B |
|
$3.51B |
|
$6.09B |
|
$1.14B |
|
$379.50M |
|
$480.87M |
|
$1.62B |
|
$4.47B |
|
$3.18B |
|
$4.47B |
|
-- |
|
| Cash Flow Statement Financials | |
$360.43M |
|
$-317.06M |
|
$-86.84M |
|
$501.87M |
|
$405.27M |
|
$-96.61M |
|
|
Stock-Based Compensation |
$14.30M |
$-120.44M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|